1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
2. Lu M, Yang Z, Feng Q, et al. The characteristics and prognostic value ofsignet ring cell histology in gastric cancer: a retrospective cohort studyof 2199 consecutive patients. Medicine (Baltimore). 2016;95(27):e4052.doi:10.1097/MD.0000000000004052
3. Zhao L, Yang C, Lin Y, Wang S, Ye Y, Shen Z. Research progress andprospects of AFP-positive gastric cancer. Foregut Surg. 2022;2(1):29-38.
4. Abdelwahab H, Tageldin O, Hasak S, Lee H. AFP-producing gastriccarcinoma. Hum Pathol. 2022;28:300640.
5. Hirajima S, Komatsu S, Ichikawa D, et al. Liver metastasis is the onlyindependent prognostic factor in AFP-producing gastric cancer. WorldJ Gastroenterol. 2013;19(36):6055.
6. Xu X, Wang Q, Cao H, et al. Prognostic value of serum alpha-fetoprotein levels in patients with gastric cancer: a meta-analysis. J IntMed Res. 2020;48(3):0300060519899780.
7. Fujikawa H, Koumori K, Watanabe H, et al. The clinical significanceof lymphovascular invasion in gastric cancer. In Vivo. 2020;34(3):1533-1539. doi:10.21873/invivo.11942
8. Lu J, Dai Y, Xie J-W, et al. Combination of lymphovascular invasionand the AJCC TNM staging system improves prediction of prognosisin N0 stage gastric cancer: results from a high-volume institution. BMCCancer. 2019;19:1-9.
9. Mei D, Zhao B, Zhang J, et al. Impact of lymphovascular invasion onsurvival outcome in patients with gastric cancer: a retrospective cohortstudy. Am J Clin Pathol. 2020;153(6):833-841.
10. Kunisaki C, Makino H, Kimura J, et al. Impact of lymphovascularinvasion in patients with stage I gastric cancer. Surgery. 2010;147(2):204-211.
11. Zhang CD, Ning FL, Zeng XT, Dai DQ. Lymphovascular invasion as apredictor for lymph node metastasis and a prognostic factor in gastriccancer patients under 70 years of age: a retrospective analysis. Int J Surg.2018;53:214-220.
12. Choi S, Song JH, Lee S, et al. Lymphovascular invasion: traditional butvital and sensible prognostic factor in early gastric cancer. Ann SurgOncol. 2021;28(13):8928-8935.
13. Japanese Gastric Cancer Association. Japanese Gastric CancerTreatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1-25. doi:10.1007/s10120-022-01331-8
14. Liu D, Li B, Yan B, et al. The clinicopathological features and prognosisof serum AFP positive gastric cancer: a report of 16 cases. Int J Clin ExpPathol. 2020;13(9):2439.
15. Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer. 2011;11(1):23.
16. Lin H, Hsieh Y, Fang W, Huang K, Li A. Clinical manifestations inpatients with alpha-fetoprotein-producing gastric cancer. Curr Oncol.2014;21(3):394-399.
17. Wang YK, Shen L, Jiao X, Zhang XT. Predictive and prognostic valueof serum AFP level and its dynamic changes in advanced gastric cancerpatients with elevated serum AFP. World J Gastroenterol. 2018;24(2):266.